Given the anti-inflammatory and bone-protective effects of HDAC inhibitors in preclinical models of periodontitis35,42, these observations also support investigation of the potential of targeting these mechanisms with epigenetic drugs to reverse the impairment of OPG production in periodontitis. Here, HDAC9 is linked to periodontitis.